Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Cyclically Adjusted Book per Share: ¥4.69 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603168 Zhejiang Shapuaisi Pharmaceutical Co Ltd SHSE:603168
37 GF Score
Price ¥4.73
GF Value ¥8.87
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zhejiang Shapuaisi Pharmaceutical Co Cyclically Adjusted Book per Share?

Zhejiang Shapuaisi Pharmaceutical Co SHSE:603168 -1.46% 37 Cyclically Adjusted Book per Share is ¥4.69 as of Mar. 2026. GuruFocus rates SHSE:603168 with a GF Score™ of 37/100 and a GF Value™ of ¥8.87 (Significantly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zhejiang Shapuaisi Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥3.542. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥4.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhejiang Shapuaisi Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 2.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Zhejiang Shapuaisi Pharmaceutical Co was 5.60% per year. The lowest was 3.10% per year. And the median was 4.35% per year.

As of today (2026-07-22), Zhejiang Shapuaisi Pharmaceutical Co's current stock price is ¥4.73. Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥4.69. Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Shapuaisi Pharmaceutical Co was 3.12. The lowest was 1.01. And the median was 1.91.


Zhejiang Shapuaisi Pharmaceutical Co  (SHSE:603168) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.73/4.69
=1.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Shapuaisi Pharmaceutical Co was 3.12. The lowest was 1.01. And the median was 1.91.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zhejiang Shapuaisi Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Zhejiang Shapuaisi Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Shapuaisi Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.86 4.26 4.35 4.54 4.67

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.58 4.60 4.65 4.67 4.69

SHSE:603168 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Shapuaisi Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:603168
37GF Score
Zhejiang Shapuaisi Pharmaceutical Co Ltd SHSE:603168
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Shapuaisi Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Shapuaisi Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.542/116.3033*116.3033
=3.542

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.168 101.400 3.634
201609 3.239 102.400 3.679
201612 4.942 102.600 5.602
201703 5.097 103.200 5.744
201706 4.969 103.100 5.605
201709 5.144 104.100 5.747
201712 5.137 104.500 5.717
201803 5.264 105.300 5.814
201806 5.141 104.900 5.700
201809 5.225 106.600 5.701
201812 4.591 106.500 5.014
201903 4.652 107.700 5.024
201906 4.671 107.700 5.044
201909 4.713 109.800 4.992
201912 4.616 111.200 4.828
202003 4.617 112.300 4.782
202006 4.560 110.400 4.804
202009 4.518 111.700 4.704
202012 4.049 111.500 4.223
202103 4.081 112.662 4.213
202106 4.132 111.769 4.300
202109 4.161 112.215 4.313
202112 4.192 113.108 4.310
202203 4.278 114.335 4.352
202206 4.303 114.558 4.369
202209 3.754 115.339 3.785
202212 4.578 115.116 4.625
202303 4.642 115.116 4.690
202306 4.741 114.558 4.813
202309 4.680 115.339 4.719
202312 4.535 114.781 4.595
202403 4.557 115.227 4.600
202406 4.459 114.781 4.518
202409 4.482 115.785 4.502
202412 4.229 114.893 4.281
202503 4.254 115.116 4.298
202506 4.291 114.907 4.343
202509 4.326 115.471 4.357
202512 3.612 115.832 3.627
202603 3.542 116.303 3.542

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥4.69 mean?
Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) has a Cyclically Adjusted Book per Share of ¥4.69 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Shapuaisi Pharmaceutical Co and its competitors.
Is Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Zhejiang Shapuaisi Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥4.69. Overall, Zhejiang Shapuaisi Pharmaceutical Co has a GF Score™ of 37/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Zhejiang Shapuaisi Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥4.69 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Shapuaisi Pharmaceutical Co and its competitors. Zhejiang Shapuaisi Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥4.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Shapuaisi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥8.87, compared to a current price of ¥4.73 — trading 46.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥4.69. Zhejiang Shapuaisi Pharmaceutical Co's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168), the current Cyclically Adjusted Book per Share is ¥4.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥4.73 is trading 46.7% below its estimated GF Value™ of ¥8.87. GuruFocus considers Zhejiang Shapuaisi Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:603168:

  • Cyclically Adjusted Book per Share: ¥4.69
  • GF Value™: ¥8.87 vs. price of ¥4.73 (46.7% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Shapuaisi Pharmaceutical Co Business Description

Address No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
37GF Score

Get the complete analysis for SHSE:603168

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.73
Price
¥8.87
GF Value